Seiji Ito
Papers
2
Total Citations
36
H-Index
2
About
Seiji Ito is a leading surgical oncologist whose work centers on advancing minimally invasive techniques for gastric and esophageal cancers. His major contributions lie in rigorously evaluating the benefits of robotic surgery over conventional laparoscopic approaches. As the principal investigator of the landmark JCOG1907 MONA LISA study, a phase III randomized controlled trial (2023, 33 citations), Ito is directly addressing whether robot-assisted gastrectomy offers superior outcomes for patients with clinical stage T1-4aN0-3 gastric cancer. This protocol tackles the recognized limitations of laparoscopy, such as motion restriction and spatial perception difficulties, by leveraging the articulated instruments of robotic systems. Beyond gastric cancer, Ito has demonstrated the feasibility of robotic surgery for complex esophageal cases, including the successful enucleation of a giant submucosal tumor in the upper esophagus (2021). His work is pivotal in shaping the evidence base for robotic oncology, with the MONA LISA study poised to influence global surgical standards. By systematically comparing robotic and laparoscopic techniques, Ito is helping to define the future role of robotics in achieving better patient outcomes and expanding the boundaries of what is surgically possible.
Research Focus
Key Achievements
Top Papers
- 1
- 2